{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:33:54Z","timestamp":1760056434544,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009930","name":"Basilea Pharmaceutica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.diagmicrobio.2019.114884","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:49:32Z","timestamp":1565207372000},"page":"114884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates"],"prefix":"10.1016","volume":"95","author":[{"given":"Ausilia","family":"Aprile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Caio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floriana","family":"Gona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Stefani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Lina","family":"Mezzatesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0005","series-title":"Pennsylvania 19087 USA","article-title":"Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne","author":"Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Eighth Edition. CLSI document M07-A10","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0010","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; M100 28th Edition 2018."},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijantimicag.2008.12.012","article-title":"Ceftobiprole: a novel cephalosporin with activity against gram-positive and gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)","volume":"34","author":"Barboura","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2019.114884_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2018.07.015","article-title":"Bactericidal activity of ceftobiprole combined with different antibiotics against selected gram-positive isolates","volume":"93","author":"Campanile","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0025","unstructured":"Cascio A, Mezzatesta ML, Odierna A, Di Bernardo F, Barberi G, Iaria C et al. Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin. Int J Infect Dis. 2014 Jan 9. pii: S1201\u20139712(13)00375\u20135."},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0030","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1128\/AAC.00029-07","article-title":"Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae","volume":"51","author":"Davies","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0035","series-title":"Antibiotics in laboratory medicine","first-page":"432","article-title":"Antimicrobial combinations","author":"Eliopoulos","year":"1991"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0040","unstructured":"EUCAST (The European Committee on Antimicrobial Susceptibility Testing). Breakpoint tables for interpretation of MICs and zone diameters. Version 8.0, 2018. http:\/\/www.eucast.org."},{"issue":"11","key":"10.1016\/j.diagmicrobio.2019.114884_bb0045","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JCM.01193-09","article-title":"Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome","volume":"47","author":"Falcone","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1469-0691.2009.02781.x","article-title":"Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy","volume":"16","author":"Falcone","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0055","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1128\/AAC.02465-14","article-title":"Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010","volume":"58","author":"Farrell","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s15010-011-0081-0","article-title":"Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit","volume":"39","author":"Gona","year":"2011","journal-title":"Infection"},{"issue":"31","key":"10.1016\/j.diagmicrobio.2019.114884_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007664","article-title":"Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury: a case report","volume":"96","author":"Gugliandolo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2003.09.006","article-title":"In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria","volume":"48","author":"Issa","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2019.114884_bb0075","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jmii.2014.12.008","article-title":"Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the surveillance of multicenter antimicrobial resistance in Taiwan (SMART)","volume":"49","author":"Jean","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"issue":"S1","key":"10.1016\/j.diagmicrobio.2019.114884_bb0080","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijantimicag.2011.01.028","article-title":"In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology","volume":"38","author":"Kresken","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0090","doi-asserted-by":"crossref","unstructured":"Mandell LA, Wunderlink RG, Anzueto A, Bartlett JG. Campbell GD, Dean NC, et al. Infectious disease Society of America\/American Thoracic Society concensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 (Suppl 2):S27\u201372.","DOI":"10.1086\/511159"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijantimicag.2009.03.015","article-title":"In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates","volume":"34","author":"Marti","year":"2009","journal-title":"Int J Antimicrobial Agents"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/mdr.2015.0160","article-title":"Colistin increases the Cidal activity of antibiotic combinations against multidrug-resistant Klebsiella pneumoniae: an in vitro model comparing multiple combination bactericidal testing at one peak serum concentration and time-kill method","volume":"22","author":"Mezzatesta","year":"2016","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0105","first-page":"63(1)","article-title":"Ceftobiprole activity against gram-positive and -negative pathogens collected from the United States in 2006 and 2016","volume":"21","author":"Pfaller","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0110","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0115","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1128\/AAC.00218-07","article-title":"Interactions of ceftobiprole with \u03b2-lactamases from molecular classes a to D","volume":"51","author":"Queenan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/dkq397","article-title":"Comparative activity of ceftobiprole against gram-positive and gram-negative isolates from Europe and the Middle East: the CLASS study","volume":"66","author":"Rossolini","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0125","doi-asserted-by":"crossref","unstructured":"American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Cri. Care Med 2005;171:388\u2013416.","DOI":"10.1164\/rccm.200405-644ST"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0130","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s40265-014-0273-x","article-title":"Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia","volume":"74","author":"Syed","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0135","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s40262-016-0418-z","article-title":"Pharmacokinetics and dosing of Ceftobiprole Medocaril for the treatment of hospital- and community-acquired pneumonia in different patient populations","volume":"55","author":"Torres","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.diagmicrobio.2010.10.032","article-title":"In vitro activity of ceftobiprole against frequently encountered aerobic and facultative gram-positive and gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study","volume":"69","author":"Waltky","year":"2011","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114884_bb0145","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319304705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319304705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:20Z","timestamp":1760003600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319304705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0732889319304705"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114884","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114884"}}